Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Svetlana Adamcova Selcanova"'
Publikováno v:
Journal of Education, Health and Sport, Vol 7, Iss 10, Pp 116-133 (2017)
BACKGROUND AND AIMS Apart from non-alcoholic steatohepatitis (NASH) as the sole etiology behind liver transplantation (LTx), non-alcoholic fatty liver disease (NAFLD)/NASH can play an important role in all the remaining etiologies of LTx. To gauge s
Externí odkaz:
https://doaj.org/article/83dd98686d2c4541a16073d23a351d9d
Autor:
Iveta Meciarova, Tomas Koller, Pavol Molcan, Lubomir Skladany, Svetlana Adamcova Selcanova, Michal Smitka, Petra Vrbova
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Muscle growth promoters are being developed for the treatment of disease-induced loss of muscle mass. Ligandrol and ostarine are selective androgen receptor modulators (SARMs) with a non-steroidal structure and a presumably more favorable
Autor:
Maria SZANTOVA, Lubomir SKLADANY, Martin JANICKO, Marian OLTMAN, Sylvia DRAZILOVA, Maria BELOVICOVA, Martin ZIMA, Viera KUPCOVA, Svetlana ADAMCOVA-SELCANOVA, Tomas KOLLER, Marek RAC, Martina JAKABOVICOVA, Tereza HLAVATA, Xenia FAKTOROVA, Zuzana DURKOVICOVA, Monika SZAMOSOVA, Peter JARCUSKA, Viliam MOJTO, Maria VORLICKOVA
Publikováno v:
Bratislavske lekarske listy. 123(7)
Non-communicable diseases are estimated to account for 90 % of total deaths and 19 % of premature deaths in Slovakia. Major preventable risk factors of premature mortality are overweight, obesity and alcohol consumption.Screening of risk factors rela
Autor:
Pavel Kohout, Olga Golubnitschaja, Viktoria Durajova, Janka Vnencakova, Juraj Svac, Michal Palkovič, Lukáš Lafférs, Daniela Janceková, Lubomir Skladany, Katarina Janickova, Svetlana Adamcova Selcanova, Tomas Koller
Publikováno v:
The EPMA Journal
Chronic liver disease management is a comprehensive approach requiring multi-professional expertise and well-orchestrated healthcare measures thoroughly organized by responsible medical units. Contextually, the corresponding multi-faceted chain of he
Autor:
Juraj Svac, Ľubomír Skladaný, Svetlana Adamcova Selcanova, Janka Vnencakova, Natalia Bystrianska, Daniela Janceková
Publikováno v:
Clinical and Experimental Hepatology
Aim of the study We set out to determine the applicability of acute-on-chronic liver failure (ACLF) diagnostic criteria and characteristics of thus defined ACLF sub-cohorts in a real-life clinical context. Material and methods Retrospective charts’
Autor:
Lubomir Skladany, Daniela Jancekova, Michal Žilinčan, Stanislav Okapec, Janka Vnencakova, Svetlana Adamcova Selcanova, Michal Kukla, Tomáš Koller
Publikováno v:
Journal of Hepatology. 77:S613-S614
Autor:
Sylvia Drazilova, Igor Andrasina, Peter Jarcuska, Marek Rac, Lubomir Skladany, Jakub Gazda, Radovan Barila, Michal Mego, Miroslav Zigrai, Dominik Safcak, Martin Janicko, Svetlana Adamcova-Selcanova
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 14
Journal of Clinical Medicine, Vol 10, Iss 3186, p 3186 (2021)
Volume 10
Issue 14
Journal of Clinical Medicine, Vol 10, Iss 3186, p 3186 (2021)
Objective: To compare NAFLD-related HCC and other etiology-related HCC and to describe predictive factors for survival in patients with NAFLD-related HCC independent of the BCLC staging system. Methods: We performed a multicenter longitudinal retrosp
Autor:
Dominik Safcak, Sylvia Drazilova, Jakub Gazda, Igor Andrasina, Svetlana Adamcova-Selcanova, Lea Balazova, Radovan Barila, Michal Mego, Marek Rac, Lubomir Skladany, Miroslav Zigrai, Martin Janicko, Peter Jarcuska
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 14; Pages: 4183
Background and Aims: Hepatocellular cancer (HCC) often occurs in geriatric patients. The aim of our study was to compare overall survival and progression-free survival between geriatric patients (>75 years) and patients younger than 75 years and to i
Autor:
Natalia Bystrianska, Beata Bachova, Jana Ciefova, Beata Skvarkova, Tomas Koller, Lubomir Skladany, Svetlana Adamcova Selcanova
Publikováno v:
Transplantation. 104:S487-S488
Publikováno v:
Annals of Transplantation
BACKGROUND Alcohol use disorders affect 10% of the European population. Alcohol-related liver disease (ALD) is the most common indication for liver transplantation in Slovakia. The aim of this study was to determine the proportion of patients with AL